- Home
- Life Sciences
- Biobanks
Biobanks Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Biobanks Market Analysis 2021
Market Size & CAGR of Biobanks Market in 2021
As per the latest research data, the global biobanks market is expected to showcase a Compound Annual Growth Rate (CAGR) of 5.2% between 2021 and 2026. The market size in 2021 was estimated to be USD 2.1 billion and is projected to reach USD 3.5 billion by the end of 2026.
COVID-19 Impact on the Biobanks Market
The COVID-19 pandemic had a significant impact on the biobanks market globally. Due to the pandemic, there was a surge in the demand for biobanking services for storing biological samples for research purposes related to the virus. This led to an increased market size and revenue for biobanks in 2021.
Biobanks Dynamics
The biobanks market is experiencing dynamic growth due to the increasing focus on precision medicine, personalized healthcare, and advancements in genomics research. The market is driven by factors such as the rising prevalence of chronic diseases, growing demand for regenerative medicine, and the need for large-scale biological sample storage.
Segments and Related Analysis
The biobanks market is segmented based on the type of samples stored, including blood products, biological fluids, human tissues, stem cells, and other genetic materials. Each segment caters to specific research requirements and contributes to the overall growth of the biobanks market.
By Region Analysis
In terms of regional analysis, North America dominated the biobanks market in 2021, followed by Europe and Asia-Pacific. The increasing number of biobanks, research collaborations, and government funding for research initiatives have propelled the market growth in these regions.
Key Market Players and Competitive Landscape
The key players in the global biobanks market include Thermo Fisher Scientific, Inc., QIAGEN, Tecan Trading AG, Hamilton Company, Becton, Dickinson and Company, and others. The market is highly competitive, with companies focusing on strategic partnerships and expansions to enhance their market presence.
Recent Happenings in the Biobanks Market
Recent developments in the biobanks market include advancements in automated sample handling systems, integration of artificial intelligence for data analysis, and the establishment of niche biobanks for rare diseases research. These initiatives are driving innovation and growth in the biobanks sector.
